Literature DB >> 18753341

Development of antibodies to PspA families 1 and 2 in children after exposure to Streptococcus pneumoniae.

Merit M Melin1, Susan K Hollingshead, David E Briles, Mika I Lahdenkari, Terhi M Kilpi, Helena M Käyhty.   

Abstract

Pneumococcal surface protein A (PspA) is an important virulence factor of Streptococcus pneumoniae. PspA exists as two major families, which include variable but serologically cross-reactive proteins. Previous studies with a family 1 PspA antigen suggested that children develop low concentrations of anti-PspA after pneumococcal carriage or infection. In this study, antibody to PspA families 1 and 2 was measured by an enzyme immunoassay of the serum and saliva of children with a history of culture-proven pneumococcal colonization and/or acute otitis media and in the serum and saliva of adults. The PspA families of the pneumococcal strains isolated from children were determined. The majority of the children had high serum and salivary anti-PspA concentrations to the PspA family they had encountered and low concentrations to the other, whereas adults had high antibody concentrations to both PspA families, both in serum and in saliva. The results suggest that children have a relatively family-specific antibody response to the PspA family they have been exposed to and that any PspA vaccine for children should contain members of both major PspA families.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753341      PMCID: PMC2565922          DOI: 10.1128/CVI.00181-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  42 in total

1.  Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades.

Authors:  Eliane N Miyaji; Daniela M Ferreira; Alexandre P Y Lopes; M Cristina C Brandileone; Waldely O Dias; Luciana C C Leite
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children.

Authors:  Birgit Simell; Terhi M Kilpi; Helena Käyhty
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

4.  Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

Authors:  Bing Ren; Alexander J Szalai; Orlanda Thomas; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

5.  Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae.

Authors:  S K Hollingshead; R Becker; D E Briles
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.

Authors:  S Rapola; V Jäntti; R Haikala; R Syrjänen; G M Carlone; J S Sampson; D E Briles; J C Paton; A K Takala; T M Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2000-09-05       Impact factor: 5.226

7.  Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children.

Authors:  A Soininen; H Pursiainen; T Kilpi; H Käyhty
Journal:  J Infect Dis       Date:  2001-08-02       Impact factor: 5.226

8.  Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae.

Authors:  A D Ogunniyi; R L Folland; D E Briles; S K Hollingshead; J C Paton
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.

Authors:  M C Vela Coral; N Fonseca; E Castañeda; J L Di Fabio; S K Hollingshead; D E Briles
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

10.  The immune response to pneumococcal proteins during experimental human carriage.

Authors:  Tera L McCool; Thomas R Cate; Gregory Moy; Jeffrey N Weiser
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  13 in total

1.  Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study.

Authors:  Ankie Lebon; Nelianne J Verkaik; Joost A M Labout; Corné P de Vogel; Herbert Hooijkaas; Henri A Verbrugh; Willem J B van Wamel; Vincent W V Jaddoe; Albert Hofman; Peter W M Hermans; Jiangtao Ma; Tim J Mitchell; Henriette A Moll; Alex van Belkum
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

2.  Association of Pneumococcal Protein Antigen Serology With Age and Antigenic Profile of Colonizing Isolates.

Authors:  Taj Azarian; Lindsay R Grant; Maria Georgieva; Laura L Hammitt; Raymond Reid; Stephen D Bentley; David Goldblatt; Mathuran Santosham; Robert Weatherholtz; Paula Burbidge; Novalene Goklish; Claudette M Thompson; William P Hanage; Kate L O'Brien; Marc Lipsitch
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

3.  A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.

Authors:  Jinfei Yu; Xiaorui Chen; Bo Li; Tiejun Gu; Xiangyu Meng; Wei Kong; Yongge Wu
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

4.  Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants.

Authors:  Jacinta P Francis; Peter C Richmond; William S Pomat; Audrey Michael; Helen Keno; Suparat Phuanukoonnon; Jan B Nelson; Melissa Whinnen; Tatjana Heinrich; Wendy-Anne Smith; Susan L Prescott; Patrick G Holt; Peter M Siba; Deborah Lehmann; Anita H J van den Biggelaar
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

5.  PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Authors:  Wei Xin; Yuhua Li; Hua Mo; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

6.  Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Authors:  Merit M Melin; Susan K Hollingshead; David E Briles; William P Hanage; Mika Lahdenkari; Tarja Kaijalainen; Terhi M Kilpi; Helena M Käyhty
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

7.  A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media.

Authors:  Jason W Rosch; Amy R Iverson; Jessica Humann; Beth Mann; Geli Gao; Peter Vogel; Michael Mina; Kyle A Murrah; Antonia C Perez; W Edward Swords; Elaine I Tuomanen; Jonathan A McCullers
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

8.  Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.

Authors:  Danielle A Wagner-Muñiz; Shannon L Haughney; Sean M Kelly; Michael J Wannemuehler; Balaji Narasimhan
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

9.  IgG responses to Pneumococcal and Haemophilus influenzae protein antigens are not impaired in children with a history of recurrent acute otitis media.

Authors:  Selma P Wiertsema; Karli J Corscadden; Eva N Mowe; Guicheng Zhang; Shyan Vijayasekaran; Harvey L Coates; Timothy J Mitchell; Wayne R Thomas; Peter C Richmond; Lea-Ann S Kirkham
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

Review 10.  Towards Identifying Protective B-Cell Epitopes: The PspA Story.

Authors:  Naeem Khan; Arif T Jan
Journal:  Front Microbiol       Date:  2017-05-02       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.